About
Approach
Investment Model
Investment Scope
Our approach
Team
Managing Partner
Partners
Our team
Portfolio
News
Connect
Watch Now: Dr. Christopher Janson: ASGCT Presentation on Myrtelle’s Phase 1/2 Gene Therapy Clinical Trial in Patients with Canavan Disease
Article Date
June 6, 2023
This article is featured on another website.
Go to article
Related posts
Browse all articles
August 14, 2026
From Bioprocessing to the Digital Age: Chime Biologics at the Bioprocessing Summit 2026
August 14, 2026
From Bioprocessing to the Digital Age: Chime Biologics at the Bioprocessing Summit 2026
June 26, 2026
The Medicine Maker – Biopharma Vital Signs: Emerging Trends
June 26, 2026
The Medicine Maker – Biopharma Vital Signs: Emerging Trends